In the evolving landscape of global healthcare, nutritional deficiencies—particularly Iron Deficiency Anemia (IDA)—remain a significant challenge affecting over 2 billion people worldwide. As a premier Ferrous Ascorbate and Folic Acid Tablets Supplier, Jiangxi Serum Pharma Industries Co., Ltd. provides a dual-action therapeutic solution designed for maximum bioavailability and minimal gastrointestinal distress.
Ferrous Ascorbate is a synthetic molecule of ascorbic acid and ferrous iron. Unlike traditional ferrous sulfate, it is absorbed in the duodenum and upper jejunum without being significantly inhibited by dietary phytates or oxalates. When combined with Folic Acid, it facilitates the maturation of red blood cells and prevents neural tube defects (NTDs) during prenatal care.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, and raw materials.
The global pharmaceutical market is shifting from inorganic iron (Ferrous Sulfate) to organic salts like Ferrous Ascorbate due to its superior safety profile. Ascorbate acts as a reducing agent, preventing the oxidation of iron to the ferric form, which is less absorbable.
Combining Folic Acid with Iron is no longer just for pregnancy. Modern trends include the addition of Zinc and Vitamin B12 to create a comprehensive hematopoietic complex that addresses multiple pathways of erythropoiesis.
Sustained-release (SR) and enteric-coated formulations are gaining traction to further reduce metallic taste and gastric irritation, ensuring higher patient compliance in long-term therapy.
Serum Pharma continuously monitors cutting-edge markets. We offer specialized services in customization to enhance product stability and efficacy.
Homogeneous blending of Ferrous Ascorbate and Folic Acid to ensure dosage uniformity across large batches.
Utilizing molecular engineering to enhance the solubility and thermal stability of active ingredients.
Clean-label sourcing of nutritional ingredients through advanced microbial fermentation processes.
We provide large-scale supply solutions for national anemia control programs, ensuring high-volume consistency and compliance with international pharmacopoeia standards (BP/USP).
Our OEM/ODM services allow for customized tablet strengths (e.g., 100mg Ferrous Ascorbate + 1.5mg Folic Acid) with localized packaging design to meet regional regulatory requirements.
With annual sales exceeding $10,000,000, our logistics network ensures that temperature-sensitive pharmaceutical shipments reach their destination with full traceability.
All our manufacturing partners are rigorously audited to ensure they meet the World Health Organization's Good Manufacturing Practices. This guarantees that every tablet of Ferrous Ascorbate and Folic Acid is pure, potent, and safe.
We provide comprehensive dossiers (CTD format), stability data, and Certificates of Analysis (CoA) to facilitate rapid product registration in your local market.
Our formulations are tested under Zone IVB (Hot and Humid) conditions to ensure efficacy remains intact even in tropical climates, a critical factor for global procurement.
We prioritize sustainable raw material sourcing, ensuring that our plant extracts and chemical intermediates are produced with minimal environmental impact.
Ferrous Ascorbate contains iron in the divalent form (Fe2+), which is the only form the human body can absorb. The presence of ascorbate prevents oxidation to the trivalent form (Fe3+), which typically causes constipation and nausea.
For most adult therapeutic uses, 1.5mg to 5mg of Folic Acid is combined with 100mg of elemental iron. However, we can customize the formulation based on specific clinical guidelines of your target country.
By leveraging our network of over 200 close-related suppliers and our high-volume export capacity, we reduce middleman costs and pass those savings directly to our global clients.
Yes, we offer sample support for qualified pharmaceutical distributors and institutions to conduct local testing and regulatory filings.
Absolutely. As mentioned in our original profile, we export vaccines and biological products, meaning we have the infrastructure to manage temperature-controlled shipping worldwide.
Exploring the shift toward sustainable sources in pharmaceutical adjuvants and nutritional ingredients.
Why this critical molecule remains a cornerstone of modern emergency and anti-inflammatory medicine.
Eli Lilly's oral small-molecule GLP1 approval marks a new era in metabolic health and weight management.
